Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease

被引:96
作者
Nagashayana, N
Sankarankutty, P
Nampoothiri, MRV
Mohan, PK
Mohanakumar, KP
机构
[1] Indian Inst Chem Biol, Div Pharmacol & Expt Therapeut, Neurochem Lab, Calcutta 700032, W Bengal, India
[2] Govt Ayurveda Coll, Dept Kayachikitsa, Trivandrum 695001, Kerala, India
[3] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum 695011, Kerala, India
关键词
Parkinson's disease; herbal medicine; Mucuna pruriens; Withania somnifera; efficacy of Ayurveda treatment; Sida cordifolia; Hyoscyamus reticulatus;
D O I
10.1016/S0022-510X(00)00329-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ayurveda, the Indian system of traditional medicine, uses a concoction of several spices, herbs and minerals for the treatment of diseases. In a clinical prospective study we have evaluated the efficacy of Ayurveda treatment (a concoction in cow's milk of powdered Mucuna pruriens and Hyoscyamus reticulatus seeds and Withania somnifera and Sida cordifolia roots) in 18 clinically diagnosed (with a mean Hoen and Yahr value of 2.22) parkinsonian patients. As per Ayurveda principles, 13 patients: underwent both cleansing (for 28 days) and palliative therapy (56 days), 5 patients underwent palliative therapy alone (84 days). Only the former group showed significant improvement in activities of daily living (ADL) and on motor examination as per UPDRS rating. Symptomatically, they exhibited better response in tremor, bradykinesia, stiffness and cramps as compared to the latter group. Excessive salivation worsened in both the groups. Analyses of powdered samples in milk, as administered in patients, revealed about 200 mg of L-DOPA per dose. The study establishes the necessity of cleansing therapy in Ayurveda medication prior to palliative therapy. It also reveals contribution of L-DOPA in the recovery as observed in Parkinson' disease following Ayurveda medication. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 8 条
[1]  
Chaudhri R.D., 1996, HERBAL DRUG IND PRAC
[2]  
DEVARAJ TL, 1986, PANCHAKARMA TREATMEN
[3]  
Husain G, 1997, PHYTOTHER RES, V11, P419
[4]  
JAIN SK, 1994, CIBA F SYMP, V185, P153
[5]  
MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392
[6]  
RICHARDSON EP, 1987, HARRISONS PRINCIPLES, P2017
[7]   Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and gabaergic markers in rat brain [J].
Schliebs, R ;
Liebmann, A ;
Bhattacharya, SK ;
Kumar, A ;
Ghosal, S ;
Bigl, V .
NEUROCHEMISTRY INTERNATIONAL, 1997, 30 (02) :181-190
[8]  
Sengupta, 1984, AYURVEDA SYSTEM MED